SUSMED, Inc. (4263) Balance sheet

Market cap
¥11.9B
P/E ratio
-22x
Susmed develops digital therapeutic apps and IT platforms that help pharmaceutical companies and healthcare providers conduct clinical trials and analyze medical data more efficiently.
2019/062020/062021/062022/062023/062024/062025/062026/06
Cash and cash equivalents -3661,6274,9045,0494,8474,3983,698
Total current assets-3791,6754,9365,0854,8984,4634,028
Property, plant and equipment, net-------6
Total non-current assets-308163440191
Total assets -3821,6754,9445,1014,9324,5034,218
Total current liabilities-239688225321126148
Total non-current liabilities-416666-
Total liabilities -269793230328132148
Retained earnings--458-278-512-563-920-1,218-1,601
Stockholders' equity4523551,5784,8504,8714,6044,3714,070
AI Chat